The global healthcare companion robots market size is likely to be valued at US$3.7 billion in 2026, and is expected to reach US$11.8 billion by 2033, growing at a CAGR of 18.0% during the forecast period from 2026 to 2033, driven by the rapidly aging global population and increasing demand for AI-powered care solutions.

The rising adoption of socially assistive and therapeutic robots across hospitals, nursing homes, and home care settings is further supporting market expansion. Healthcare companion robots are intelligent autonomous or semi-autonomous systems designed to provide emotional support, cognitive stimulation, physical assistance, and remote monitoring for elderly individuals, post-operative patients, and people living with chronic or mental health conditions.

Driver - Rapid Global Aging Population and Rising Caregiver Shortage

The global elderly population aged 65 and above is projected to reach 1.6 billion by 2050, up from around 761 million in 2021, according to the United Nations. This demographic shift is creating an unprecedented demand for scalable, technology-driven caregiving solutions as healthcare systems worldwide face a significant and growing caregiver deficit. The World Health Organization (WHO) estimates a global shortage of 10 million healthcare workers by 2030, with the caregiver gap disproportionately affecting eldercare and long-term care settings.

Healthcare companion robots help address the growing shortage of caregivers. They provide continuous monitoring, medication reminders, cognitive engagement, and emotional support. This reduces the need for constant human supervision. These robots have become valuable solutions for nursing homes, assisted living facilities, and home care settings. They improve operational efficiency while supporting patient care.

Restraint - High Initial Cost and Reimbursement Uncertainty

The high cost of advanced healthcare companion robots remains a major barrier to adoption. This is especially true for community nursing homes, rehabilitation centers, and home care settings in emerging markets. Advanced AI-enabled companion robots can cost between US$10,000 and over US$100,000 per unit, depending on their features. Additional expenses for software subscriptions, maintenance, and staff training further increase the total cost of ownership.

Limited reimbursement is another major challenge. Most healthcare systems have not established clear reimbursement policies for companion robots. The U.S. Centers for Medicare & Medicaid Services (CMS) and many European national health insurance systems do not provide dedicated reimbursement codes for these devices in non-surgical applications. This makes it difficult for healthcare providers to justify the investment.

Opportunity - Mental Health and Pediatric Care Applications

The global mental health crisis is creating a major opportunity for healthcare companion robots. The World Health Organization (WHO) estimates that more than 1 billion people worldwide live with a mental health disorder. This is increasing demand for therapeutic robotic solutions. Companion robots can support psychological care, cognitive behavioral therapy, and pediatric mental health treatment. They are also used for autism spectrum disorder (ASD), pediatric anxiety, and adult depression. These robots provide scalable, stigma-free, and cost-effective support alongside clinical care.

The NAO robot has been used in therapy programs for children with ASD. Clinical studies in Europe and North America have shown improvements in social interaction and communication skills. These results highlight the clinical effectiveness and commercial potential of companion robots in specialized therapeutic applications.

Product Type Insights

Socially assistive robots are expected to dominate the product type segment, commanding around 42% of total market revenue in 2026. Their leadership is driven by widespread use in elderly care, hospital patient engagement, and mental health support. AI-powered interaction and emotion recognition help improve patient outcomes and operational efficiency. SoftBank Robotics' Pepper and Intuition Robotics' ElliQ are among the leading commercially deployed socially assistive robots. They are widely used in nursing homes and hospitals across North America, Europe, and Japan.

Robotic pets and animal-like companion robots are expected to be the fastest-growing product type. Growth is driven by strong clinical evidence supporting their use in dementia care and pediatric mental health. Their animal-like design helps reduce patient anxiety and increases acceptance compared with humanoid robots. The PARO Therapeutic Robot continues to expand its presence in dementia and Alzheimer's care facilities worldwide. Its adoption highlights the strong clinical and commercial potential of this segment.

Technology Insights

AI and natural language processing (NLP) are expected to dominate the technology segment, capturing around 45% of market revenue in 2026. These technologies enable natural speech interaction and intent recognition. They also support personalized responses and continuous learning from patient interactions. This makes healthcare companion robots more effective in elderly care, mental health, and chronic disease management.

Machine learning and emotion recognition are expected to be the fastest-growing technology segment. Growth is driven by increasing demand for robots that can detect and respond to patients' emotional states and behavioral patterns. These technologies can also identify early signs of cognitive or physical decline. Their use is expanding in dementia monitoring, pediatric therapy, and post-operative mental health support.

Application Insights

Elderly care and assisted living are expected to dominate the application segment, accounting for around 39% of total revenue in 2026. Growth is driven by the increasing elderly population worldwide. Healthcare companion robots provide medication reminders, fall detection, social interaction, and cognitive stimulation. These features make them well suited for nursing homes, assisted living facilities, and home care settings.

Pediatric and mental health support is expected to be the fastest-growing application segment. Growth is driven by the global rise in mental health disorders. Increasing clinical acceptance of robot-assisted therapy for autism spectrum disorder (ASD), depression, and pediatric anxiety is also supporting demand. Expanding insurance coverage for digital mental health services in countries such as the U.S., U.K., and Germany is further boosting market growth.

End-user Insights

Hospitals and clinics are expected to dominate the market, accounting for over 35% of revenue in 2026. Growth is driven by increasing use of companion robots for patient engagement, elderly care, mental health support, and workload reduction. For example, SoftBank Robotics developed Pepper, a humanoid robot that assists with patient interaction, guidance, and emotional support in hospitals.

Home care settings are expected to be the fastest-growing segment. Growth is driven by the aging population, rising prevalence of chronic diseases, and increasing demand for aging-in-place solutions. AI-powered companion robots support health monitoring, medication adherence, caregiver communication, and social engagement. For example, Intuition Robotics developed ElliQ, an AI companion for older adults. It provides social interaction, wellness support, medication reminders, and family connectivity.

North America Healthcare Companion Robots Market Trends

North America is projected to dominate the market, commanding around 38% of the global revenue in 2026. The region benefits from advanced healthcare infrastructure and high adoption of AI technologies. Strong venture capital investment in healthcare robotics also supports growth. A favorable regulatory environment for digital health and robotic medical devices further strengthens the market.

U.S. Healthcare Companion Robots Market Trends

The U.S. is expected to account for around 86% of North America revenue in 2026. Growth is driven by annual healthcare spending of more than US$4.5 trillion. The country also has a well-established eldercare industry that uses companion robots in nursing homes and assisted living facilities. The presence of leading companies such as Intuition Robotics, Diligent Robotics, Jibo, Inc., and iRobot further supports market growth.

Canada Healthcare Companion Robots Market Trends

Canada is expected to account for around 14% of North America revenue in 2026. Growth is supported by the country's aging-in-place strategy. Provincial healthcare systems are increasingly adopting AI-based care technologies to reduce costs. Expanding university research in therapeutic and assistive robotics is also contributing to market growth.

Europe Healthcare Companion Robots Market Trends

Europe is expected to be the second-largest market, accounting for around 27% of the global revenue in 2026. Growth is supported by well-developed eldercare systems and universal healthcare coverage. Strong public investment in assistive technologies for aging populations also drives adoption of healthcare companion robots.

Germany Healthcare Companion Robots Market Trends

Germany is expected to be the largest market in Europe, accounting for around 24% of regional revenue in 2026. Growth is driven by the country's rapidly aging population. More than 22% of German citizens are aged 65 and above. Government investment in digital nursing home care under the Digitale Pflegeanwendungen (DiPA) framework also supports the market. Research institutions such as the Fraunhofer Institute for Manufacturing Engineering and Automation (Fraunhofer IPA) are advancing companion robotics for healthcare and eldercare applications.

U.K. Healthcare Companion Robots Market Trends

The U.K. is projected to account for around 20% of Europe revenue in 2026. Growth is supported by the National Health Service (NHS), which is increasingly adopting AI-powered robotic care solutions. These technologies help address care worker shortages and reduce hospital readmissions through AI-enabled home monitoring and patient engagement.

Asia Pacific Healthcare Companion Robots Market Trends

Asia Pacific is expected to be the fastest-growing regional market. Growth is driven by Japan's strong focus on care robotics. Large investments in smart healthcare infrastructure in China also support the market. Healthcare digitization in India and expanding geriatric care across Southeast Asia are further boosting growth.

Japan Healthcare Companion Robots Market Trends

Japan is expected to hold the largest share in Asia Pacific, accounting for around 30% of regional revenue in 2026. Growth is driven by the world's highest proportion of elderly people. The Japanese government's national robotics strategy actively promotes the use of care robots in nursing homes. The presence of leading companies such as Toyota and SoftBank Robotics also supports the market.

China Healthcare Companion Robots Market Trends

China is expected to account for around 26% of Asia Pacific revenue in 2026. Growth is supported by the government's Healthy China 2030 strategy. Large investments in AI and robotics manufacturing are also driving the market. The country's rapidly aging population, which is projected to exceed 300 million elderly people by 2035, further increases demand for healthcare companion robots.

The global healthcare companion robots market features a dynamic competitive landscape comprising dedicated social robotics specialists, diversified industrial robot manufacturers extending into healthcare, AI software platform companies, and emerging startups focusing on specific therapeutic applications. SoftBank Robotics, with its Pepper and NAO platforms, maintains a structurally advantaged position through its global commercial scale, established hospital and care facility customer base, and comprehensive AI software ecosystem for healthcare applications.

Intuition Robotics, developer of the ElliQ AI companion for elderly users, has established a strong commercial position in the home-based eldercare segment through its subscription-based service model, proactive health engagement capabilities, and partnerships with home care agencies and health systems in the U.S. and Israel. PARO Robots U.S., Inc. continues to dominate the therapeutic robotic pet segment with its FDA-cleared PARO therapeutic robot, widely deployed in dementia, Alzheimer’s, and psychiatric care settings across over 30 countries with strong clinical evidence supporting its efficacy.

Key Industry Developments:

• In March 2024, Franka Robotics launched the Franka AI Companion, a robotics platform with advanced tactile capabilities that improved research productivity and accelerated innovation in robotics.
• In January 2024, Intuition Robotics launched ElliQ 3, an upgraded AI companion for seniors that integrated generative AI to enhance interactions, promote independence, and reduce social isolation.